These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 31706167)

  • 1. Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.
    Gmuca S; Hardy DI; Narula S; Stoll S; Harris J; Zhao Y; Xiao R; Weiss PF; Waldman AT; Gerber JS
    Mult Scler Relat Disord; 2020 Jan; 37():101488. PubMed ID: 31706167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a claims-based algorithm to identify patients with Neuromyelitis Optica Spectrum disorder.
    Patel AM; Exuzides A; Yermilov I; Dalglish H; Gibbs SN; Reddy SR; Chang E; Paydar C; Broder MS; Cohan S; Greenberg B; Levy M
    J Neurol Sci; 2024 Aug; 463():123110. PubMed ID: 38964269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
    Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
    Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of South Indian patients.
    Kanikannan MA; Arepareddy PK; Mathukumalli NL; Y S; Kandadai RM; Jabeen AS; T S; Borgohain R
    Mult Scler Relat Disord; 2019 Oct; 35():164-169. PubMed ID: 31382202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment.
    Baghbanian SM; Asgari N; Sahraian MA; Moghadasi AN
    J Neurol Sci; 2018 May; 388():222-231. PubMed ID: 29478727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
    Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
    Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
    Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
    Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
    Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
    J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
    Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
    Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica.
    Bennett JL
    J Neuroophthalmol; 2016 Sep; 36(3):238-45. PubMed ID: 27529327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiari malformation Type I surgery in pediatric patients. Part 1: validation of an ICD-9-CM code search algorithm.
    Ladner TR; Greenberg JK; Guerrero N; Olsen MA; Shannon CN; Yarbrough CK; Piccirillo JF; Anderson RC; Feldstein NA; Wellons JC; Smyth MD; Park TS; Limbrick DD
    J Neurosurg Pediatr; 2016 May; 17(5):519-24. PubMed ID: 26799412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
    Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
    Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2015 IPND Criteria Increases the Yield in Diagnosis of Neuromyelitis Optica Spectrum Disorder in Thai Patients Compared to the 2006 Diagnostic Criteria.
    Rattanathamsakul N; Kaveeta C; Siritho S; Thakolwiboon S; Prayoonwiwat N
    Mult Scler Relat Disord; 2020 Aug; 43():102218. PubMed ID: 32474289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
    Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
    Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
    Domingos J; Isidoro L; Figueiredo R; Brum M; Capela C; Barros P; Santos E; Macário Mdo C; Pinto Marques J; Pedrosa R; Vale J; Sá MJ
    Clin Neurol Neurosurg; 2015 Jul; 134():79-84. PubMed ID: 25965287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
    Wingerchuk DM; Banwell B; Bennett JL; Cabre P; Carroll W; Chitnis T; de Seze J; Fujihara K; Greenberg B; Jacob A; Jarius S; Lana-Peixoto M; Levy M; Simon JH; Tenembaum S; Traboulsee AL; Waters P; Wellik KE; Weinshenker BG;
    Neurology; 2015 Jul; 85(2):177-89. PubMed ID: 26092914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.